Safety and tolerability of ubrogepant for the acute treatment of migraine in participants taking atogepant for the preventive treatment of episodic migraine: Results from the TANDEM study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2025, v. 65, n. 6, p. 1005, doi. 10.1111/head.14871
- By:
- Publication type:
- Article